Navigating the future of cell therapies with exec Kathryn Corzo

Kathryn Corzo is currently the president and chief operating officer of The Cambridge, UK–based synthetic biology company specializes in providing human cells for research, drug discovery and cell therapy.

Her previous roles include a stint as the head of development for oncology cell therapies at Takeda. She also led the North American Innovation Center and R&D Digital Accelerator at Sanofi and held a leadership role in Lilly’s oncology business unit.’s differentiated approach

Corzo’s decision to join was rooted in the company’s pioneering approach to cell therapy. “Joining became a clear choice,” she recalls. “The platform technology at offers a solution to some of the significant challenges in the cell therapy field, mainly by manufacturing consistent cells at scale, speed and reduced costs thus democratizing access to human cells.…

Read more
  • 0